| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863771 Sugar, food and process of forming sugar |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/21/1999 | WO1999002678A1 Wa545 compositions |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002504A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | WO1999002168A1 Novel polymeric compositions |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002133A2 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891773A1 Use of gamma-linolenic acid for preventing oxydative stress |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/20/1999 | EP0637310B1 Water-soluble retinoids |
| 01/20/1999 | CN1205631A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205630A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205230A Chinese medicine for treating seborrheic baldness |
| 01/20/1999 | CN1205225A External-use medicine for treating superficial skin fungus disease |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861149 Methods for wound treatment |
| 01/19/1999 | US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation |
| 01/19/1999 | CA2122923C Compositions for regulating skin wrinkles and/or skin atrophy |
| 01/19/1999 | CA2121484C Treatment of acne or of pseudofolliculitis barbae |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | DE19729143A1 Herbal ointment for treating dry, flaky skin |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294770A1 Compounds and methods |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889881A1 New triazoles as therapeutic agents for fungal infections |
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859253 Metalloproteinase inhibitors |
| 01/12/1999 | US5859061 Matrix metalloproteinase inhibitors; treating diseases involving connective tissue degradation |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859034 Tri-substituted phenyl compounds which have useful pharmaceutical activity |
| 01/12/1999 | US5859029 Heterocyclic compounds method of preparing them and pharmeutical compositions in which they are present |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5858993 Administering to accelerate wound healing, stimulate hair growth |
| 01/12/1999 | US5858991 Administering a polysaccharide toxin to reduce scarring and to provide reduced vessel density at the site of the wound |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858390 Preparation of cultured undifferentiated mesenchymal cells and injection of the cell preparation |
| 01/12/1999 | US5858017 Urologic irrigation solution and method for inhibition of pain, inflammation and spasm |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000406A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 01/07/1999 | WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | WO1999000109A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract |
| 01/07/1999 | WO1999000079A1 Skin aging and wound treatment using cell migration agents |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0888784A1 Cellulose ester wound dressing |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888351A1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 01/07/1999 | EP0888349A1 Pyrrolopyrimidines and processes for their preparation |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |